Jaume Pons's Colleagues at ALX Oncology
Jaume Pons's Contact Details
HQ
["(353) 161-8000"]
["(353) 161-8000"]
Location
Company
ALX Oncology
ALX Oncology
Jaume Pons's Company Details
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology's lead product candidate, evorpacept (also known as ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. Evorpacept has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.
Frequently Asked Questions about Jaume Pons
Jaume Pons currently works for ALX Oncology.
Jaume Pons's role at ALX Oncology is President and CEO.
Jaume Pons's email address is ***@alxoncology.com. To view Jaume Pons's full email address, please signup to ConnectPlex.
Jaume Pons works in the Biotechnology industry.
Jaume Pons's colleagues at ALX Oncology are Michael Chang, Steffen P., Hank Stern, Andrew Olson, Abraham Fong, Michael Warner, Tim Welliver and others.
Jaume Pons's phone number is ["(353) 161-8000"]